About
At Provectus, we are obsessed with technologies that impact the future of the whole of humanity. Just imagine: AI for curing eye diseases, ML for making factories safe for workers, preventing pandemic spreading, etc. It’s not about the future, it’s about the products we’ve already developed with ProvectusTeam.
Updates & Highlights
Stock Titan · 5 days ago
[Form 4] PROVECTUS BIOPHARMACEUTICALS, INC. Insider Trading Activity
Kalkine Media · 7 days ago
PROVECTUS BIOPHARMACEUTICALS CEO Edward Pershing Increases Holdings to 2,936,277 Derivative Securities After Exercising Options
Stock Titan · 8 days ago
[Form 4] PROVECTUS BIOPHARMACEUTICALS, INC. Insider Trading Activity
Recent Openings
View all 7 jobs arrow_forwardAll Jobs
Culture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Provectus?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recent[Form 4] PROVECTUS BIOPHARMACEUTICALS, INC. Insider Trading Activity
[Form 4] PROVECTUS BIOPHARMACEUTICALS, INC. Insider Trading Activity
Stock Titan · 5 days ago
PROVECTUS BIOPHARMACEUTICALS CEO Edward Pershing Increases Holdings to 2,936,277 Derivative Securities After Exercising Options
PROVECTUS BIOPHARMACEUTICALS CEO Edward Pershing Increases Holdings to 2,936,277 Derivative Securities After Exercising Options
Kalkine Media · 7 days ago
[Form 4] PROVECTUS BIOPHARMACEUTICALS, INC. Insider Trading Activity
[Form 4] PROVECTUS BIOPHARMACEUTICALS, INC. Insider Trading Activity
Stock Titan · 8 days ago
Revenue per share of Provectus Biopharmaceuticals, Inc. – OTC:PVCT
Revenue per share of Provectus Biopharmaceuticals, Inc. – OTC:PVCT
TradingView · 26 days ago
Provectus: Q2 Earnings Snapshot
Provectus: Q2 Earnings Snapshot
AOL.com · about 1 month ago
Provectus: Q2 Earnings Snapshot
Provectus: Q2 Earnings Snapshot
finance.yahoo.com · about 1 month ago
Provectus: Q2 Earnings Snapshot
Provectus: Q2 Earnings Snapshot
KING5.com · about 1 month ago
Provectus: Q2 Earnings Snapshot
Provectus: Q2 Earnings Snapshot
kare11.com · about 1 month ago
Provectus: Q2 Earnings Snapshot
Provectus: Q2 Earnings Snapshot
kens5.com · about 1 month ago
Provectus Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
Provectus Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
marketscreener.com · about 1 month ago
PROVECTUS BIOPHARMACEUTICALS, INC. 2Q 2026: Revenue $0 Net loss $(982,566), EPS $(0.00) — 10-Q Summary
PROVECTUS BIOPHARMACEUTICALS, INC. 2Q 2026: Revenue $0 Net loss $(982,566), EPS $(0.00) — 10-Q Summary
TradingView · about 1 month ago
Provectus Biopharmaceuticals (PVCT) narrows loss but flags going concern risk
Provectus Biopharmaceuticals (PVCT) narrows loss but flags going concern risk
Stock Titan · about 1 month ago
Provectus Capital Partners completes acquisition of majority stake in Romania’s Seatbelt Consulting
Provectus Capital Partners completes acquisition of majority stake in Romania’s Seatbelt Consulting
romania-insider.com · about 1 month ago
Romania: Provectus Capital Partners completes acquisition of majority stake in Seatbelt Consulting
Romania: Provectus Capital Partners completes acquisition of majority stake in Seatbelt Consulting
Investors in Healthcare · about 1 month ago
Provectus completes acquisition of majority stake in Romania's Seatbelt
Provectus completes acquisition of majority stake in Romania's Seatbelt
SeeNews · about 1 month ago
Provectus Announces Release of Its Open-Source Data Discovery and Observability Platform
Provectus Announces Release of Its Open-Source Data Discovery and Observability Platform
HPCwire · about 1 month ago
Provectus Biopharmaceuticals, Inc. Revenue Breakdown – OTC:PVCT
Provectus Biopharmaceuticals, Inc. Revenue Breakdown – OTC:PVCT
TradingView · about 2 months ago
Form 13D/A PROVECTUS BIOPHARMACEUTICALS For: 22 July By Investing.com
Form 13D/A PROVECTUS BIOPHARMACEUTICALS For: 22 July By Investing.com
Investing.com South Africa · about 2 months ago
Provectus Biopharmaceuticals (PVCT) CEO holds 52.4M shares, 11.61% stake
Provectus Biopharmaceuticals (PVCT) CEO holds 52.4M shares, 11.61% stake
Stock Titan · about 2 months ago
Form 13D/A PROVECTUS BIOPHARMACEUTICALS For: 22 July By Investing.com
Form 13D/A PROVECTUS BIOPHARMACEUTICALS For: 22 July By Investing.com
Investing.com Nigeria · about 2 months ago